Clare Hague on Drug Pricing and Market Access

We talk to Clare Hague, Senior Director, Haematology Market Access, Europe, the Middle East, and Africa, Janssen. She shares her perspective on the industry's drug pricing challenges and opportunities, details alternative pricing systems that could improve access in low-to-middle-income countries, and explores the shifting market access landscape within oncology.